Want to buy for someone else? You can purchase a token at check out.
Overview
An update for healthcare professionals’ knowledge about the care of patients with chlamydia.Goals and Learning Outcomes
In 2017, more than 1.7 million cases of Chlamydia trachomatis infection were reported to the Centers for Disease Control, making chlamydia the most commonly reported notifiable disease in the United States. Due to the asymptomatic nature of this infection, it was estimated that a significant number of undiagnosed people were not represented in the statistical data. Many healthcare providers are unfamiliar with the frequency of this infection and its potentially permanent impact on people of reproductive age.
Demographic findings can guide healthcare practitioners in screening and detecting chlamydia. For example, the highest incidence of this infection occurs in young adults from ethnic minorities.2 Numerous antibiotic therapies are available for infected patients and their sexual partners; post-treatment follow-up is recommended. One of the most important roles clinicians can play is in primary prevention, before risky sexual practices take place. This continuing education program updates healthcare professionals’ knowledge about the diagnosis and care of patients with chlamydia.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Atlanta: U.S. Department of Health and Human Services; 2018. https://www.cdc.gov/std/stats17/toc.htm. Published 2018. Accessed Sept. 16, 2019.
- Explain how the pathophysiology of chlamydia infection causes two negative outcomes.
- List four risk factors and three signs and symptoms of chlamydia infection.
- Describe four educational measures that can reduce the risk of recurrent chlamydia infections in patients of reproductive age.
Course Details
Course Originally Released on : 11/1/2019
REL-ACU-0-CE145-60
Course Author
BSN, RN
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.